12-20-11 Celsense, Inc. is Issued Patent for MRI Cell Tracking Product
08-20-11 Celsense, Inc. Launches a New Dual-mode Imaging Agent Enabling Inflammation Detection by MRI and Fluorescence
06-27-11 Celsense, Inc. Announces First Clinical Trial Authorization by the US Food and Drug Administration (FDA) for Use of Its Cell Tracking Imaging Product Cell Sense
More News...
Cell Sense: A Reagent to Non-Invasively Track the Delivery, Migration and Persistence of Cells Administered for Therapeutic and Diagnostic Purposes (PDF)
V-Sense: A Versatile Reagent to Accelerate the Quantification of Inflammation in Tissue (PDF)